The Asian invasion is thought out strategetic planned move by CBG with manufacturing, production and sales of Canntab and Pharmocann products.
perhaps another month on the sidelines to relist, yet fast tracking with products for revenue and SP rise...
Asia is a HUGE potential market to customers already in the know of MM products and food consumables than Australia at the moment...